SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CRIS, Curis (formerly CBMI)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
668 42 0 CRIS
Emcee:  Norton Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
643A first-in-human, first-in-class, phase (ph) I study of systemic Hedgehog (Hh) pIcebrg-5/16/2008
642Curis initiated with "outperform" - update 05/13/08 - RBC Capital MarkIcebrg-5/14/2008
641First-in-Class Trial Shows Hedgehog Signal Inhibitor Fights Basal Cell CarcinomaIcebrg-4/17/2008
640doesn"t sound like they vetted him well enough, soon enough! Embarassing! Hphilip oraby-3/28/2008
639<i>"I am enthusiastic about my appointment to Curis' board,"Icebrg-3/25/2008
638Exelixis and Bristol-Myers Squibb to Co-Develop XL139, an Inhibitor of the HedgeIcebrg-1/22/2008
637>>Is this a step forward for Cris?>> Yes, definitively. In the futuIcebrg-12/29/2007
636thanks for the info...what are your thoughts? Is this a step forward for Cris? Cphilip oraby-12/29/2007
635Stryker Picks Up Curis' BMP-7 Program Where Ortho Left Off By Trista MorrisIcebrg-12/29/2007
634Curis, Inc. Announces Sale of its BMP-7 Assets to Stryker Corporation Friday DecIcebrg-12/28/2007
633Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb Thursday DecembeIcebrg-12/20/2007
632I noticed that institutional holdings in CRIS increased by nearly 30% (net gain tom r. phillips-12/14/2007
631Curis, Inc. Reports Decision to Advance a Systemically Administered Hedgehog AntIcebrg-12/12/2007
630Infinity Announces Hedgehog Pathway Inhibitor Agreement With AstraZeneca [UnforIcebrg-11/12/2007
629Curis Announces Presentation at CHI's ''Discovery on Target: DevelopIcebrg-10/17/2007
628background for today's announcement (from January, 2007): Curis, Inc. Annoutom r. phillips-10/16/2007
627Curis, Inc. Announces Initiation of Expansion Cohort in Collaborator Genentech&#Icebrg-10/16/2007
626Curis Provides Program Update on Development Candidate CUDC-101 and Its Targetedtom r. phillips-9/25/2007
625Curis: The Wall Street Analyst Forum Presentation Transcript seekingalpha.comIcebrg-9/21/2007
624Well worth a visit: curis.com ErikIcebrg-9/16/2007
623<i>The private placement was really done at the bottom</i> Yup, it Mike McFarland-8/13/2007
622No, I don't think so. If they did, they would have an advantage in normal trIcebrg-8/7/2007
621In a private placement, do new investors get a peek at something not yet made puMike McFarland-8/7/2007
620Curis plans to raise $12.9M in private placement Monday August 6, 1:37 pm ET CMike McFarland-8/6/2007
619Hedgehog--Genentech has a 50-patient phase I systemically administered Hedgehog Mike McFarland-8/4/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News